Sees FY23 revenue $2.244B-$2.274B, consensus $2.36B.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMED:
- Amedisys Partners with BlueCross BlueShield of Tennessee to Provide Palliative Care at Home to Members
- Amedisys Announces Divestiture of its Personal Care Division
- Amedisys Reports Fourth Quarter and Year-End 2022 Financial Results, Issues 2023 Guidance, Announces Sale of Its Personal Care Line of Business and Signs Innovative Palliative Care at Home Partnership With BlueCross BlueShield of Tennessee
- Amedisys management to meet virtually with Truist
- Amedisys announces $100M stock repurchase program